微创技术在重症急性胰腺炎中的应用进展前景

赵 宏宇
青海大学附属医院

摘要


急性胰腺炎（AP）是一种常见的消化系统疾病，病因包括胆石症、酗酒等，临床表现为急性上腹痛、恶心呕
吐等。其严重程度根据亚特兰大分类可分为轻度、中度和重症急性胰腺炎（SAP）。SAP患者病情复杂，约20%-30%的
患者可能会出现胰腺感染坏死，死亡率较高。近年来，随着医学技术的发展，微创技术逐渐成为治疗SAP的重要手段。
经皮穿刺引流、内镜介入及腹腔镜手术在降低手术创伤、减少并发症及加速康复方面表现出显著优势。本文综述了这
三种微创技术在SAP治疗中的应用，探讨了其优势与局限性。尽管微创技术具有减少术后疼痛、加快康复的优点，但
对于复杂病例，可能仍需结合传统开放手术进行治疗。未来应进一步完善这些技术，为患者提供更优的治疗方案。

关键词


急性胰腺炎；重症急性胰腺炎；微创手术；经皮穿刺引流；内镜介入

全文:

PDF


参考


[1]李慧臻，周正华，程红杰，杨岩：急性胰腺炎

中医诊疗专家共识（2023）.中华中医药杂志，2024，39

（07）：3549-3557.

[2]Banks PA, Bollen TL, Dervenis C, Gooszen HG,

Johnson CD, Sarr MG, Tsiotos GG, Vege SS: Classification of

acute pancreatitis—2012: revision of the Atlanta classification

and definitions by international consensus. Gut 2013,

62(1):102-111.

[3]Leppäniemi A, Tolonen M, Tarasconi A, SegoviaLohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry

N, Sartelli M, Wolbrink D: 2019 WSES guidelines for the

management of severe acute pancreatitis. World journal of

emergency surgery 2019, 14:1-20.

[4]Iannuzzi JP, King JA, Leong JH, Quan J, Windsor

JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ,

Shaheen A-A: Global incidence of acute pancreatitis is

increasing over time: a systematic review and meta-analysis.

Gastroenterology 2022, 162(1):122-134.

[5]Petrov MS, Yadav D: Global epidemiology

and holistic prevention of pancreatitis. Nature reviews

Gastroenterology & hepatology 2019, 16(3):175-184.

[6]Alzerwi N: Surgical management of acute pancreatitis:

Historical perspectives, challenges, and current management

approaches. World Journal of Gastrointestinal Surgery 2023,

15(3):307.

[7]李非，黄铂涵，曹锋：感染性胰腺坏死的微创外

科处理策略、技术及评价.中国实用外科杂志，2024，44

（05）：512-516.

[8]Van Santvoort HC, Besselink MG, Bakker OJ,

Hofker HS, Boermeester MA, Dejong CH, van Goor H,

Schaapherder AF, van Eijck CH, Bollen TL: A step-up

approach or open necrosectomy for necrotizing pancreatitis.

New England journal of medicine 2010, 362(16):1491-1502.

[9]Bakker OJ, van Santvoort HC, van Brunschot S,

Geskus RB, Besselink MG, Bollen TL, van Eijck CH, Fockens

P, Hazebroek EJ, Nijmeijer RM: Endoscopic transgastric vs

surgical necrosectomy for infected necrotizing pancreatitis: a

randomized trial. Jama 2012, 307(10):1053-1061.

[10]Farias GFA, Bernardo WM, De Moura DTH,

Guedes HG, Brunaldi VO, Visconti TAdC, Gonçalves CVT,

Sakai CM, Matuguma SE, Santos MELd et al: Endoscopic

versus surgical treatment for pancreatic pseudocysts: Systematic

review and meta-analysis. Medicine 2019, 98(8):e14255.

[11]Cheung M-T, Li W-H, Kwok PC-H, Hong

JK-F: Surgical management of pancreatic necrosis: towards

lesser and later. Journal of hepato-biliary-pancreatic sciences

2010, 17:338-344.

[12]Freeman ML, Werner J, Van Santvoort HC, Baron

TH, Besselink MG, Windsor JA, Horvath KD, Bollen TL,

Vege SS: Interventions for necrotizing pancreatitis: summary

of a multidisciplinary consensus conference. Pancreas 2012,

41(8):1176-1194.

[13]Windsor JA: Minimally invasive pancreatic

necrosectomy. British Journal of Surgery 2007, 94(2):132-133.

[14]Bello B, Matthews JB: Minimally invasive treatment

of pancreatic necrosis. World journal of gastroenterology:

WJG 2012, 18(46):6829.

[15]Seifert H, Wehrmann T, Schmitt T, Zeuzem S,

Caspary WF: Retroperitoneal endoscopic debridement

for infected peripancreatic necrosis. The Lancet 2000,

356(9230):653-655.

[16]Wilson C, McArdle C, Carter D, Imrie C: Surgical

treatment of acute necrotizing pancreatitis. British journal of

surgery 1988, 75(11):1119-1123.


Refbacks

  • 当前没有refback。